Literature DB >> 17314363

Molecular typing of a Legionella pneumophila outbreak in Ontario, Canada.

Matthew W Gilmour1,2, Kathryn Bernard1,2, Dobryan M Tracz2, Adam B Olson2, Cindi R Corbett2, Tamara Burdz2, Betty Ng2, Deborah Wiebe2, George Broukhanski3, Peter Boleszczuk3, Patrick Tang3, Frances Jamieson3, Gary Van Domselaar2, Francis A Plummer1,2, Jody D Berry2.   

Abstract

An outbreak of Legionnaires' disease at a long-term care facility in Ontario, Canada from September to October 2005 resulted in the death of 23 residents and the illness of 112 other people. In response, molecular methods were developed to detect Legionella pneumophila in clinical lung samples and to subtype isolates from clinical and environmental samples. The targeted genetic loci included Legionella-specific virulence determinants (mip, icmO, sidA and lidA) and core bacterial determinants (ftsZ, trpS and dnaX). An established amplified fragment length polymorphism typing method provided the first indication of genetic relatedness between strains recovered from clinical samples and strains cultured from environmental samples taken from the outbreak site. These associations were verified using the European Working Group for Legionella Infections sequence-based typing protocol targeting the flaA, pilE, asd, mip, mompS and proA loci. These molecular typing methods confirmed the outbreak source as a contaminated air conditioning cooling tower.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314363      PMCID: PMC2884934          DOI: 10.1099/jmm.0.46738-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


INTRODUCTION

Legionella pneumophila is a ubiquitous bacterium in natural aquatic environments that can also persist in human-controlled systems containing water, such as air conditioning and plumbing infrastructures. Intracellular growth in protozoa can permit this pathogen to survive chlorination, and the generation of aerosols in these systems contributes to the transmission to humans where infection of alveolar macrophages results in respiratory illness (Steinert ; McDade ). The first recognized outbreak of Legionnaires' disease occurred in 1976 in Philadelphia, USA, and Legionella is now accepted as a significant cause of community- and nosocomial-acquired pneumonia, including in long-term care facilities (Seenivasan ). During outbreaks of Legionnaires' disease the recovery or detection of L. pneumophila in clinical specimens can be sufficient for detection of the aetiological agent. However, due to the ubiquitous nature of this bacterium in the environment, molecular typing methods are needed both to determine the relatedness of outbreak strains and for definitive identification of the outbreak source. Culture of clinical specimens (e.g. from the lower respiratory tract) is the gold standard for diagnosis of Legionnaires' disease but rapid detection of L. pneumophila serogroup 1, the most common subtype associated with human disease, can be achieved with immunofluorescence and serological assays targeting L. pneumophila antigen and L. pneumophila-specific antibodies, respectively (Fields ). Molecular detection of genus and species is through assays targeting characteristic sites in the rRNA and mip genes, respectively (Fields ; Ballard ; Wilson ; Rantakokko-Jalava & Jalava, 2001). The mip locus is also one of six loci used in a sequence-based typing (SBT) scheme for the molecular subtyping of L. pneumophila strains (Gaia ). The mip locus therefore encodes conserved species-specific polymorphisms useful for molecular diagnostics and also strain-specific polymorphisms that can distinguish amongst L. pneumophila isolates. The effectiveness of the SBT scheme for determining the genetic relatedness of L. pneumophila outbreak-associated strains, in comparison to other subtyping methods such as PFGE, has been previously demonstrated (Scaturro ). In this study, molecular reagents were developed during an outbreak of Legionnaires' disease for the detection of L. pneumophila in clinical specimens and typing of clinical and environmental isolates.

METHODS

The case definition of Legionnaires' disease was chest X-ray confirmed pneumonia, clinical diagnosis or pathological evidence of pneumonia at autopsy, and living or working within 3 kilometres (1.9 miles) of the outbreak site since a month prior to the outbreak. Each case of Legionnaires' disease was definitively confirmed after a positive culture for L. pneumophila serogroup 1, a positive urine antigen test (Binax) or positive immunofluorescence antibody serology (standing titre of ⩾1 : 256 or fourfold seroconversion of ⩾1 : 128). Legionella strains were recovered from clinical specimens and environmental samples as described by Wilkinson (1988) and Fields (1994). Briefly, Legionella spp. from environmental samples were first selected using buffered charcoal yeast agar (BCYE) plates supplemented with polymyxin B, anisomycin and vancomycin (PAV). Colonies resembling Legionella spp. on the BCYE-PAV plates were then differentiated using BCYE, BCYE (lacking cysteine) and blood agar plates. Isolation of Legionella spp. from lung samples was performed using solely BCYE plates. All incubations were performed at 37 °C in candle jars or CO2 incubators. Lung autopsy materials were transported in viral transport media, swabs and water samples were collected in sterile containers, and air samples were collected with a XMX-CV aerosol collection system (Dycor). Direct fluorescent antibody assay (DFA) analysis on clinical specimens were done using monoclonal or polyclonal DFA products directed towards L. pneumophila serogroups (Prolab and Monofluo L. pneumophila kit; Bio-Rad). Additionally, total DNA was prepared from 19 lung autopsy samples from 7 patients using the DNeasy tissue extraction kit (Qiagen). Oligonucleotides designed for molecular detection and typing are described in Table 1. PCR was performed using these oligonucleotides (1 μM), dNTPs (0.2 mM), magnesium sulfate (2 mM), Tris/sulfate (60 mM; pH 8.9), ammonium sulfate (18 mM) and 0.5 U High Fidelity Platinum Taq polymerase (Invitrogen) per 25 ml reaction, and the following thermocycling conditions: 94 °C for 5 min; 35 cycles of 94 °C for 30 s, 55 °C for 30 s and 68 °C for 30 s (except with sidA, lidA and icmO 1 min); and a one-round final extension at 68 °C for 5 min. DNA sequencing was performed with the oligonucleotides used to generate the amplicon. SBT using targets designed by the European Working Group for Legionella Infections (EWGLI) and amplified fragment length polymorphism (AFLP) analysis were performed as described by Gaia , 2005) and Valsangiacomo .
Table 1.

Oligonucleotides developed in this study for the detection and subtyping of L. pneumophila

TargetOligonucleotideSequence (5′ to 3′)Product size (bp)Purpose*
dnaXGIL296ATACCTGTGTTGCCATTGAGC255PCR-Lpn ID
GIL297ATTTTTGTGGGTCAGTCGTTGPCR-Lpn ID
dnaXGIL313TTTGCGCTGGTGTATTATCATC936 (with GIL296)PCR-sequencing
ftsZGIL298GCGATTGCATCTCCTTTATTG351PCR-Lpn ID
GIL299CTGAGCCTGCTTACGAATCACPCR-Lpn ID
ftsZGIL312CGATGCACAAGCTTTAAGAGG946 (with GIL299)PCR-sequencing
trpSGIL300TCAGCCTAATTTGTCGATTGG274PCR-Lpn ID
GIL301TTGCCAAACAGGACATTTTTCPCR-Lpn ID
trpSGIL308TTGATTGGCTAGCTTGTGGAG999PCR-sequencing
GIL309AATCAAGCCCCATGACTTCTCPCR-sequencing
mipGIL306GCTTTAACCGAACAGCAAATG267PCR-Lpn ID
GIL307AACGGTACCATCAATCAGACGPCR-Lpn ID
lidAGIL314TCACATCAAGTTAAAACATCAG882PCR-Lpn ID
GIL315ATGCTCACGCTGTAAGGATTGPCR-Lpn ID
icmOGIL316AATTTTCGGTTCAACGGGTAG763PCR-Lpn ID
GIL317CAGTGCGGGTAATAAAACCACPCR-Lpn ID
sidAGIL318GAAATTCGTGCCATAGAACTCC330PCR-Lpn ID
GIL319CGGGGCTATGATTTCTTCTATGPCR-Lpn ID

*Lpn ID, L. pneumophila-specific detection.

RESULTS AND DISCUSSION

An outbreak of Legionnaires' disease at an extended care facility in Scarborough, Ontario, Canada, from September to October, 2005 resulted in 23 deaths. All mortalities occurred with residents of the care facility (hereafter, ‘outbreak site’) and additional cases were identified in 47 residents, 39 staff and 21 visitors to the outbreak site, as well as in 5 occupants and staff of a neighbouring care facility and residence (hereafter, ‘adjacent site’). A total of 82 people were affected with symptoms resembling Legionnaires' disease and 53 people presented with the milder form of illness cause by Legionella, Pontiac fever. A total of 79 people were hospitalized, of which 54 were residents at the outbreak site. This study describes the molecular detection of L. pneumophila in the lung autopsy material from the first mortalities, and the subtyping of L. pneumophila strains subsequently isolated from clinical and environmental samples. Molecular detection of L. pneumophila in lung tissue DNA extractions and subtyping of pure cultures was achieved using species-specific oligonucleotides (Table 1). These were designed for various genetic loci after comparative analyses of the complete sequence data from three L. pneumophila group 1 strains (Lens, Paris and Philadelphia: GenBank accession numbers NC_006369, NC_006368 and NC_002942, respectively) and with the other publicly available bacterial sequences. Oligonucleotides corresponded to conserved regions amongst the three L. pneumophila genomes, but were unique compared to other genera and/or species (data not shown). The target loci included Legionella-specific virulence determinants (mip, icmO, sidA and lidA) and core bacterial determinants (ftsZ, trpS and dnaX). These core bacterial determinants have been predicted to contain species-specific polymorphisms (Zeigler, 2003), and we have previously utilized ftsZ and trpS for speciation of Vibrio spp. and detection of Salmonella enterica serovar Typhi, respectively (Tracz , 2007). Published primer sets specific for the Legionella genus (16S rRNA) and human β-globin locus were used as additional control reactions (Raggam ; Keller & Mannack, 1993). PCR-based detection assays for L. pneumophila were conducted on 19 lung tissue DNA extractions (from 7 different patients) using ftsZ, trpS, dnaX and mip L. pneumophila-specific primer sets; control reactions included 293T tissue culture cells spiked with Legionella micdadei ATCC 33218 or spiked with L. pneumophila ATCC 33153 (Table 2). Using this approach, all clinical lung samples were positive for the presence of L. pneumophila, except for a single lung tissue extract (05-L-025, patient 3). The two other lung specimens from patient 3 were positive for L. pneumophila and the control PCR reactions for specimen 05-L-025 failed, indicating that DNA extraction was likely unsuccessful for this individual specimen. DFA testing on one lung autopsy specimen from each patient was positive for L. pneumophila serogroup 1, whereas L. pneumophila was cultured from lung specimens for six of the seven patients.
Table 2.

PCR-based detection of L. pneumophila

Templates included clinical lung autopsy material and tissue culture spiked with live bacterial culture (prepared using a Qiagen tissue extraction kit) or pure bacterial culture (prepared from boiled cell lysates).

Sample*PatientDescriptiondnaXftsZtrpSmip16S†β-globin‡
L. pneumophila ATCC 33153naPure culture+++++
L. micdadei ATCC 33218naPure culture+
293T tissue culturenaTissue culture+
293T+L. pneumophilanaSpiked tissue++++++
293T+L. micdadeinaSpiked tissue++
05-L-0111Autopsy tissue++++++
05-L-012 (DFA+)1Autopsy tissue++++++
05-L-0131Autopsy tissue++++++
05-L-0142Autopsy tissue++++++
05-L-0152Autopsy tissue++++++
05-L-024 (DFA+)2Autopsy tissue++++++
05-L-0163Autopsy tissue++++++
05-L-0173Autopsy tissue++++++
05-L-025 (DFA+)3Autopsy tissue
05-L-0184Autopsy tissue++++++
05-L-0194Autopsy tissue++++++
05-L-027 (DFA+)4Autopsy tissue++++++
05-L-0205Autopsy tissue++++++
05-L-0215Autopsy tissue++++++
05-L-026 (DFA+)5Autopsy tissue++++++
05-L-0226Autopsy tissue++++++
05-L-0236Autopsy tissue++++++
05-L-028 (DFA+)6Autopsy tissue++++++
05-L-029 (DFA+)7Autopsy tissue++++++

na, Not applicable.

*DFA+, DFA detected L. pneumophila serogroup 1 in the clinical specimen.

†Legionella genus-specific primers (Raggam ).

‡Human-specific primers (Keller & Mannack, 1993).

Environmental sampling was performed throughout the outbreak site and the adjacent site, including cooling towers, air filtration systems and internal plumbing systems. Samples included sediments and biofilms in these infrastructure, collection of standing and free-flowing water, and collection of air-borne particulate matter. Additionally, sampling was performed of the soil and natural water systems in the surrounding area, which included a ravine and creek directly behind the outbreak site. Notably, PCR-based detection of L. pneumophila directly in environmental samples failed, including those that ultimately were cultured for this organism. The amount of L. pneumophila DNA extracted from these samples was likely below the detection threshold for these methods, and therefore these methods might be limited to analysis of pure culture and clinical samples. The only environmental samples that yielded L. pneumophila isolates were associated with the cooling towers at both the outbreak and adjacent sites (Table 3). Isolates 05-L-77, -79, -192 and -193 were typed as serogroup 1, corresponding to the same serogroup observed in the lung autopsy material by DFA analysis.
Table 3.

SBT of L. pneumophila isolates cultured from lung autopsy tissue or from environmental samples

The allele profile number for each locus is indicated. AFLP analysis was performed on selected isolates and the patterns correlated to those illustrated in Fig. 1.

StrainSite of collection; AFLP resultflaApilEasdmipmompSproA
05-L-013Lung, patient 1219510181
05-L-025Lung, patient 3219510181
05-L-026Lung, patient 5219510181
05-L-028Lung, patient 6219510181
05-L-029Lung, patient 7219510181
060017Lung, patient 4; pattern A219510181
060018Lung, patient 1; pattern B219510181
060019Outbreak site, cooling tower; pattern A219510181
060020Outbreak site, cooling tower middle cavity; pattern B219510181
05-L-0192-1Outbreak site, cooling tower bottom cavity219510181
05-L-0192-2Outbreak site, cooling tower bottom cavity219510181
05-L-0192-3Outbreak site, cooling tower bottom cavity219510181
05-L-0192-4Outbreak site, cooling tower bottom cavity219510181
05-L-0192-5Outbreak site, cooling tower bottom cavity219510181
05-L-0192-6Outbreak site, cooling tower bottom cavity219510181
05-L-0192-7Outbreak site, cooling tower bottom cavity219510181
05-L-0193Outbreak site, cooling tower219510181
CPHL-3Adjacent site; pattern C143111
CPHL-5Adjacent site; pattern C143111
CPHL-7Adjacent site; pattern C143111
05-L-077-1Adjacent site, west cooling tower143111
05-L-079-2Adjacent site, east cooling tower143111
ATCC 33153L. pneumophila group 1 (Knoxville) reference strain761732411
To discriminate the environmental isolates beyond the level of serogroup, and to determine genetic relatedness to the lung isolates, AFLP analysis was used as a rapid molecular typing method (Fig. 1). The AFLP pattern produced from adjacent site isolates was different than the patterns obtained for both the outbreak site cooling tower and lung isolates, wherein two similar (but non-identical) patterns were observed amongst both groups of these outbreak-associated isolates. These data provided the first indication that the cooling tower at the outbreak site was responsible for the event.
Fig. 1.

AFLP analysis of outbreak-associated (A, B) and adjacent site (C) isolates. Molecular mass markers are indicated.

The clinical and environmental L. pneumophila isolates were also prepared as template for DNA sequencing using the ftsZ, trpS, dnaX, icmO, sidA and lidA loci. Phylogenetic comparisons indicated that each of the lung isolates and strains recovered from the cooling tower at the outbreak site had identical genotypes at all loci (Fig. 2). Furthermore, the outbreak site and lung isolates had a different genotype at all loci in comparison to reference strains and strains isolated at the adjacent site, whereas the adjacent site isolates had identical genotypes as the endemic ‘Paris' strain. SBT using an established protocol (Gaia , 2003) was also utilized to determine the genetic relatedness of the isolates (Table 3), and the allelic profile of the lung-associated strains was again identical to the strains recovered from the outbreak site cooling tower, but different from the profile of isolates from the adjacent site. Notably, none of the individual SBT alleles reported in this study were novel to the database maintained by EWGLI, but the cumulative profile of the outbreak strain had not been reported before and therefore no associations to previously examined strains were evident. However, the isolates from the cooling tower of the adjacent site encoded the most frequently recorded profile in the EWGLI database (N. Fry, personal communication).
Fig. 2.

Genetic relatedness of outbreak, environmental and reference L. pneumophila strains. Phylogeny is based upon a neighbour-joining tree of the concatenated segments of core bacterial loci (trpS, ftsZ and trpS) and Legionella-specific virulence determinants (lidA, icmO, sidA, total 4243 nucleotides per entry). GenBank accession numbers for previously sequenced loci are presented in the text, and strains from the current study are abbreviated from the form 05-L-0XX to LXX. The source is indicated in parentheses. Bar, scale of the distance score.

Molecular reagents were developed during this outbreak of Legionnaires' disease to supplement bacterial culture and immunological detection methods for L. pneumophila in clinical lung specimens. Additional validation will be required to confirm the specificity and sensitivity of the primer sets in other clinical samples such as bronchial alveolar lavage fluid and urine. Molecular typing analyses (both SBT and AFLP) demonstrated that isolates from the cooling tower at the outbreak site were related to isolates from lung autopsy specimens, but divergent from isolates recovered from an adjacent building and reference strains. Notably, AFLP analyses distinguished two clones amongst the human and environmental outbreak-associated isolates suggesting increased sensitivity for this method; however, the nature of the observed genetic diversity was undefined. The genetic loci developed in this study for SBT effectively determined the relatedness of clinical and environmental samples, but the established EWGLI SBT protocol was of increased utility because it similarly differentiated the L. pneumophila strains but additionally allowed for comparison to a global collection of SBT data deposited in a web-accessible database.
  15 in total

Review 1.  Legionnaires' disease in long-term care facilities: overview and proposed solutions.

Authors:  Meena H Seenivasan; Victor L Yu; Robert R Muder
Journal:  J Am Geriatr Soc       Date:  2005-05       Impact factor: 5.562

2.  Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila.

Authors:  Valeria Gaia; Norman K Fry; Baharak Afshar; P Christian Lück; Hélène Meugnier; Jerome Etienne; Raffaele Peduzzi; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Comparison of three molecular methods used for subtyping of Legionella pneumophila strains isolated during an epidemic of Legionellosis in Rome.

Authors:  M Scaturro; M Losardo; G De Ponte; M L Ricci
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Development of conventional and real-time PCR assays for detection of Legionella DNA in respiratory specimens.

Authors:  K Rantakokko-Jalava; J Jalava
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Use of amplified fragment length polymorphism in molecular typing of Legionella pneumophila and application to epidemiological studies.

Authors:  C Valsangiacomo; F Baggi; V Gaia; T Balmelli; R Peduzzi; J C Piffaretti
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  Single-run, parallel detection of DNA from three pneumonia-producing bacteria by real-time polymerase chain reaction.

Authors:  Reinhard B Raggam; Eva Leitner; Jörg Berg; Gerhard Mühlbauer; Egon Marth; Harald H Kessler
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

7.  Sequence-based typing of Legionella pneumophila serogroup 1 offers the potential for true portability in legionellosis outbreak investigation.

Authors:  Valeria Gaia; Norman K Fry; Timothy G Harrison; Raffaele Peduzzi
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Detection of Legionella pneumophila by real-time PCR for the mip gene.

Authors:  Deborah A Wilson; Belinda Yen-Lieberman; Udo Reischl; Steve M Gordon; Gary W Procop
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

Review 10.  Legionella pneumophila: an aquatic microbe goes astray.

Authors:  Michael Steinert; Ute Hentschel; Jörg Hacker
Journal:  FEMS Microbiol Rev       Date:  2002-06       Impact factor: 16.408

View more
  18 in total

1.  Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology.

Authors:  Victoria Ng; Patrick Tang; Frances Jamieson; Steven J Drews; Shirley Brown; Donald E Low; Caroline C Johnson; David N Fisman
Journal:  Ecohealth       Date:  2009-04-16       Impact factor: 3.184

Review 2.  From Evolutionary Advantage to Disease Agents: Forensic Reevaluation of Host-Microbe Interactions and Pathogenicity.

Authors:  Jessica I Rivera-Pérez; Alfredo A González; Gary A Toranzos
Journal:  Microbiol Spectr       Date:  2017-01

Review 3.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Legionella pneumophila monoclonal antibody subgroups and DNA sequence types isolated in Canada between 1981 and 2009: Laboratory Component of National Surveillance.

Authors:  A R Reimer; S Au; S Schindle; K A Bernard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-04       Impact factor: 3.267

5.  Prevalence of sequence types among clinical and environmental isolates of Legionella pneumophila serogroup 1 in the United States from 1982 to 2012.

Authors:  Natalia A Kozak-Muiznieks; Claressa E Lucas; Ellen Brown; Tracy Pondo; Thomas H Taylor; Michael Frace; Diane Miskowski; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

6.  Evaluation of a nested-PCR-derived sequence-based typing method applied directly to respiratory samples from patients with Legionnaires' disease.

Authors:  Christophe Ginevra; Marie Lopez; Françoise Forey; Monique Reyrolle; Helene Meugnier; François Vandenesch; Jerome Etienne; Sophie Jarraud; Maëlle Molmeret
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

7.  External quality assessment of a DNA sequence-based scheme for epidemiological typing of Legionella pneumophila by an international network of laboratories.

Authors:  Baharak Afshar; Norman K Fry; William Bellamy; Anthony P Underwood; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

8.  The secreted pyomelanin pigment of Legionella pneumophila confers ferric reductase activity.

Authors:  Christa H Chatfield; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

9.  New endemic Legionella pneumophila serogroup I clones, Ontario, Canada.

Authors:  Nathalie Tijet; Patrick Tang; Mya Romilowych; Carla Duncan; Victoria Ng; David N Fisman; Frances Jamieson; Donald E Low; Cyril Guyard
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

10.  Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006.

Authors:  Victoria Ng; Patrick Tang; Frances Jamieson; Cyril Guyard; Donald E Low; David N Fisman
Journal:  BMC Infect Dis       Date:  2009-05-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.